These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 8258837

  • 1. (1-Butyl-4-piperidinyl)methyl 8-amino-7-chloro-1,4-benzodioxane-5-carboxylate hydrochloride: a highly potent and selective 5-HT4 receptor antagonist derived from metoclopramide.
    Gaster LM, Jennings AJ, Joiner GF, King FD, Mulholland KR, Rahman SK, Starr S, Wyman PA, Wardle KA, Ellis ES.
    J Med Chem; 1993 Dec 10; 36(25):4121-3. PubMed ID: 8258837
    [No Abstract] [Full Text] [Related]

  • 2. N-[(1-butyl-4-piperidinyl)methyl]-3,4dihydro-2H-[1,3]oxazino[3,2- a]indole10-carboxamide hydrochloride: the first potent and selective 5-HT4 receptor antagonist amide with oral activity.
    Gaster LM, Joiner GF, King FD, Wyman PA, Sutton JM, Bingham S, Ellis ES, Sanger GJ, Wardle KA.
    J Med Chem; 1995 Nov 24; 38(24):4760-3. PubMed ID: 7490724
    [No Abstract] [Full Text] [Related]

  • 3. 5-HT4 receptor antagonist affinities of SB207710, SB205008, and SB203186 in the human colon, rat oesophagus, and guinea-pig ileum peristaltic reflex.
    McLean PG, Coupar IM.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug 24; 352(2):132-40. PubMed ID: 7477435
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Arylcarbamate derivatives of 1-piperidineethanol as potent ligands for 5-HT4 receptors.
    Soulier JL, Yang D, Brémont B, Croci T, Guzzi U, Langlois M.
    J Med Chem; 1997 May 23; 40(11):1755-61. PubMed ID: 9171886
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM, Thompson DC, Bloomquist WE, Susemichel AD, Calligaro DO, Cohen ML.
    J Med Chem; 1998 May 21; 41(11):1943-55. PubMed ID: 9599243
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preparation and in vitro pharmacology of 5-HT4 receptor ligands. Partial agonism and antagonism of metoclopramide analogous benzoic esters.
    Elz S, Keller A.
    Arch Pharm (Weinheim); 1995 May 21; 328(7-8):585-94. PubMed ID: 7492263
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the densities of 5-HT4 receptors, beta 1- and beta 2-adrenoceptors in human atrium: functional implications.
    Kaumann AJ, Lynham JA, Brown AM.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr 21; 353(5):592-5. PubMed ID: 8740155
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is the action of cisapride on the guinea-pig ileum mediated via 5-HT4 receptors?
    Meulemans AL, Schuurkes JA.
    Eur J Pharmacol; 1992 Feb 25; 212(1):51-9. PubMed ID: 1555639
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ability of mosapride to bind to 5-HT4 receptor in the human stomach.
    Sakurai-Yamashita Y, Takada K, Takemura K, Yamashita K, Enjoji A, Kanematsu T, Taniyama K.
    Jpn J Pharmacol; 1999 Apr 25; 79(4):493-6. PubMed ID: 10361891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.